MikhailVinogradovMD

Oncology • Myrtle Beach, SC

Physician at Tidelands Health

Join to view full profile

Dr. Vinogradov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Vinogradov's full profile

Already have an account?

Office
1220 21st Ave N
Unit 140
Myrtle Beach, SC 29579
Is this information wrong?

Education & Training

Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2008
Vidant Medical Center/East Carolina UniversityResidency, Internal Medicine, 2004
Vidant Medical Center/East Carolina UniversityInternship, Internal Medicine, 2001 - 2002
Samara State Medical UniversityClass of 1986
Donetsk medical instituteMD, medical student, 1980 - 1984

Certifications & Licensure

GA State Medical License 2014 - 2025
SC State Medical License 2014 - 2025
NC State Medical License 2001 - 2024
VA State Medical License 2015 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Internal Medicie Oncology Hematology

Publications & Presentations

PubMed

4 citations
Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
Arminder Singh, Lam Nguyen, Stephanie Everest, Mikhail Vinogradov> ;Cureus. 2021 Nov 29
5 citations
Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer.
Walter D.Y. Quan, Mikhail Vinogradov, Francine M. Quan, Nawazish Khan, Darla K. Liles, Paul R. Walker> ;Cancer Biotherapy & Radiopharmaceuticals. 2006 Nov 6
1 citations
Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.
Walter D.Y. Quan, Paul R. Walker, Francine M. Quan, Maria Ramirez, Haitham M Elsamaloty, Vikas Ghai, Mikhail Vinogradov, Darla K. Liles> ;Cancer Biotherapy & Radiopharmaceuticals. 2006 Nov 6
3 citations
Correlation Between Development of Pulmonary Edema and Response of Pulmonary Metastases of Metastatic Melanoma and Kidney Cancer to High-Dose Continuous-Infusion Inter...
Walter D.Y. Quan, Nawazish Khan, Maria Ramirez, W. Chris Taylor, Francine M. Quan, Mikhail Vinogradov, Paul R. Walker> ;Cancer Biotherapy & Radiopharmaceuticals. 2005 May 3
16 citations
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over
Walter D.Y. Quan, Maria Ramirez, Chris Taylor, Francine M. Quan, Mikhail Vinogradov, Paul R. Walker> ;Cancer Biotherapy & Radiopharmaceuticals. 2005 Mar 18
6 citations
High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer.
Walter D.Y. Quan, Maria Ramirez, Chris Taylor, Mikhail Vinogradov, Francine M. Quan, Nawazish Khan> ;Cancer Biotherapy & Radiopharmaceuticals. 2005 Mar 18
11 citations
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
Walter D.Y. Quan, Maria Ramirez, W. Chris Taylor, Mikhail Vinogradov, Nawazish Khan, Shawn Jackson> ;Cancer Biotherapy & Radiopharmaceuticals. 2004 Dec 1
13 citations
Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma.
Walter D.Y. Quan, W. G. Brick, Mikhail Vinogradov, W. Chris Taylor, Nawazish Khan, Russell Burgess> ;Cancer Biotherapy & Radiopharmaceuticals. 2004 Aug 25
Join now to see all